Shares of Labcorp Holdings Inc. LH inched 0.34% higher to $229.92 Monday, on what proved to be an all-around mixed trading ...

LabCorp and University Health System settle on $388,667 for alleged False Claims Act violations related to Medicare billing.

The Federal Circuit rejected Laboratory Corporation of America Holdings’ challenge of a competitor’s fetal DNA test patent ...

The Federal Circuit on Monday, January 6, rejected Labcorp's argument that the Patent Trial and Appeal Board erred in its ...

The U.S. Attorney's Office said the two corporations delayed certain laboratory tests by Caris Life Sciences between March ...

The bank upgraded Labcorp's stock on expectations of solid lab volume growth, accretive revenues from Labcorp's Invitae business, and margin expansion in 2025.

Labcorp Holdings Inc. LH, or Labcorp, is targeting high-growth areas as part of its expansion. By partnering with health systems and regional local laboratories, the company is leveraging science and ...

With a market cap of $19.2 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company specializing in ...

University Health System and Labcorp pay $388,667 to resolve False Claims Act allegations of improper billing to Medicare for lab tests.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Labcorp Holdings Inc. closed $18.84 short of its 52-week high ($247.99), which the company achieved on November 11th.